Article
DARE to Resist White Supremacy and The Police
American policing is a white supremacist institution that has repeatedly demonstrated the degree to which it values property over human life.
Article
American policing is a white supremacist institution that has repeatedly demonstrated the degree to which it values property over human life.
Article
Aldous Huxley’s thoughts on “progress” in capitalist democracies, why people take drugs, and the role of psychedelics in people’s lives.
Article
Sexual violence is already notoriously under-reported, and barriers— including distrust in police—are amplified when victims are also members of a criminalized subculture and were under the influence of illegal drugs when the violence occurred.
Article
The grief we live with during the COVID-19 pandemic is political.
Article
“I want nothing to do with those kinds of folks who want to decriminalize psychedelics,” Rahn told Forbes.”
Article
Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.
Article
Jamon A. Rahn, CEO of psychedelic pharmaceutical startup MindMed, offered a glimpse of the future of psychedelic science, including proprietary data and hints of an “LSD neutralizer.”
Article
Contributors to the Daily Psychedelic Video platform gather on Zoom to bless the opening of the Psychedelic Video Museum: a collection of ten years’ worth of their shared visions.
Article
‘Debbie and Doug Drop Acid in the Desert’ director, Scott Brown, talks mind-altering drugs, creating psychedelic visual effects, and dealing with depression.
Article
Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.
Article
As the coronavirus pandemic rages on, Christian Angermayer, the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences, calls to sacrifice public health for the sake of “the economy.”
Article
In response to the coronavirus pandemic, Christian Angermayer—the world’s largest psychedelic pharmaceutical investor and founder of ATAI Life Sciences—dismisses medical experts in his desperation to reboot the economy.
Psymposia is a research and media 501(c)(3) nonprofit that offers critical perspectives on drugs, politics, and culture.
We rely on audience support to keep our work independent and focused on the public interest. You can sustain Psymposia by becoming a member, which includes exclusive content and perks.